This redirect does not require a rating on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||
|
The contents of the Pigmented villonodular synovitis page were merged into Tenosynovial giant cell tumor on 6 August 2020 and it now redirects there. For the contribution history and old versions of the merged article please see its history. |
The
Wikimedia Foundation's
Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see
WP:PAID. For advice about reviewing paid contributions, see
WP:COIRESPONSE.
|
You should certainly add the article. You may want to categorize it with other joint conditions. - Cyborg Ninja 10:18, 27 July 2007 (UTC)
Worst case is not joint replacement. It is amputation. I know that first hand. PVNS survivor. — Preceding unsigned comment added by 2602:301:77E2:C6F0:E950:8ECA:A225:914C ( talk) 03:40, 2 May 2017 (UTC)
This edit request by an editor with a conflict of interest has now been answered. |
NOTE: I am proposing this edit for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.
I am submitting this edit request to bring your attention to the fact that the World Health Organization reclassified pigmented villonodular synovitis (PVNS) and giant-cell tumor of the tendon sheath (GCT-TS) to “tenosynovial giant cell tumor” or “TGCT” in 2013 in its 4th edition of WHO Classification of Tumours of Soft Tissue and Bone [1] (paid subscription required) to encompass a family of lesions in the soft tissue surrounding large & small joints, which all share a common pathogenesis.
As you know, this is a rare disease with very limited online resources, and the scientific and medical community are continually learning more about the condition. There are several resources containing information about TGCT, and a few are provided below, which should not be considered all-inclusive. Publications about TGCT have been posted by:
We gather it is your objective to ensure the community has as much accurate and up-to-date information possible. Toward that end, we’re requesting that the existing PVNS page be updated to include “TGCT” as an overarching name for the condition as adopted by the World Health Organization and the National Organization for Rare Disorders.
Thank you for your consideration. Jon Gray ( talk) 22:55, 31 October 2018 (UTC)
References
Tenosynovial giant cell tumor (TGCT), previously pigmented villonodular synovitis (PVNS), is a rare, proliferative neoplasm affecting the synovial lining of joints, bursae, and tendons sheaths.
{{
cite journal}}
: Cite journal requires |journal=
(
help)CS1 maint: multiple names: authors list (
link)
{{
cite journal}}
: Cite journal requires |journal=
(
help)CS1 maint: multiple names: authors list (
link)
{{
cite web}}
: Missing or empty |title=
(
help)
{{
cite web}}
: Missing or empty |title=
(
help)
{{
cite web}}
: Missing or empty |title=
(
help)
{{
requested move}}
specifically as a controversial move request process requiring discussion amongst the wider community. More information may be found at
requested moves.If choice number two above is your intention, kindly change the {{
request edit}}
template's answer parameter to read from |ans=yes
to |ans=no
Regards,
Spintendo
07:53, 1 November 2018 (UTC)
This edit request by an editor with a conflict of interest was declined. Per MOS:LEADLINK. |
NOTE: I am proposing this edit for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.
@ Spintendo: As a follow up to your request for clarification, our request is submitted with the intention of adding a passage to the existing first sentence of this page which introduces diffuse-type tenosynovial giant cell tumor as an alternate name for PVNS. Requested verbatim addition (bolded) and sourcing follow:
Thank you for your consideration. Jon Gray ( talk) 16:05, 6 December 2018 (UTC)
References
Tenosynovial giant cell tumour, diffuse type; Synonyms: Diffuse-type giant cell tumour; pigmented villonodular synovitis; pigmented villonodular, tenosynovitis
Regards, Spintendo 02:05, 7 December 2018 (UTC)
References
NOTE: I am seeking clarification for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.
@ Spintendo: Thanks for your response. To clarify, are you/the guideline suggesting that introducing the alternate term for the condition may be better suited later in the article? If so, we're happy to submit an alternate recommendation for the edit to abide by that guideline. Please let me know your thoughts. Jon Gray ( talk) 22:18, 7 December 2018 (UTC)
This edit request by an editor with a conflict of interest has now been answered. |
NOTE: I am re-flagging the previous request for additional clarification for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.
Following up on the previous communication, I am re-flagging our request for additional clarification (submitted 12/7/2018) to the declined edit request in the hopes that @ Spintendo: or another COI editor can provide clarity on whether or not introducing the alternate term for the condition may be better suited later in the article (perhaps the Classification section) as to not violate MOS:LEADLINK. If so, I can submit a revised edit request with verbatim language and sourcing for consideration.
Thank you. Jon Gray ( talk) 00:04, 11 January 2019 (UTC)
References
Notes
Pinging @ Rod57: for their input on this, as they are the editor who created the redirect for TGCT that the COI editor is attempting to place in this article. Are you able to confirm that these conditions, TGCT and PVS, are the same? Please advise if possible, thanks! Spintendo 00:53, 11 January 2019 (UTC)
NOTE: I am proposing this edit for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.
Thank you both for your responses!
@ Spintendo:, as @ Rod57: mentioned, I included references from third-parties ( World Health Organization and National Institutes of Health [1]; [2] to validate the claim that tenosynovial giant cell tumor (TGCT) was introduced as an alternate name for PVNS. Both were referenced in the original request (dated 10/31/18, which required follow-up clarification/verbatim recommendations from me) and the WHO reference was included as the primary reference in our follow up request (dated 12/6/18). (The cross-linked Wiki page was not intended to serve as a source to add the alternate title for the condition to the article itself, but was related to the secondary request for page cross-linking. Apologies for any confusion on that.)
However, I would like to re-submit our request to include TGCT as an alternate name for PVNS in the article. Please see below for an updated edit request, which hopefully will avoid any issues with MOS:LEADLINK. The source for this requested addition is the aforementioned World Health Organization reference which identifies tenosynovial giant cell tumor (diffuse type) as a synonym for PVNS (see quote in reference code below confirming the conditions as synonyms).
Classification
Our request is submitted with the intention of adding a sentence to the end of the “Classification” section to introduce diffuse-type tenosynovial giant cell tumor (TGCT) as an alternate name for PVNS. The requested verbatim addition and sourcing (from World Health Organization, which validates the synonyms – see quote in reference) follow:
Thanks again for your time and consideration. Jon Gray ( talk) 23:19, 28 January 2019 (UTC)
References
Tenosynovial giant cell tumor (TGCT), previously pigmented villonodular synovitis (PVNS), is a rare, proliferative neoplasm affecting the synovial lining of joints, bursae, and tendons sheaths.
{{
cite journal}}
: Cite journal requires |journal=
(
help)CS1 maint: multiple names: authors list (
link)
{{
cite journal}}
: Cite journal requires |journal=
(
help)CS1 maint: multiple names: authors list (
link)
Tenosynovial giant cell tumour, diffuse type; Synonyms: Diffuse-type giant cell tumour; pigmented villonodular synovitis; pigmented villonodular, tenosynovitis
Please move to WP:MERGEREQ
Please feel free to contact
Wikipedia:WikiProject Merge if you require additional assistance with your request.
Regards,
Spintendo
00:45, 29 January 2019 (UTC)
Notes
NOTE: I am proposing this discussion for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.
At the recommendation of a conflict of interest editor who I’d previously contacted about adding Tenosynovial giant cell tumor (TGCT) as a synonym for diffuse-type pigmented villonodular synovitis (PVNS), I am opening this merger discussion to ask the community for guidance on how to go about updating the language describing tenosynovial giant cell tumor (TGCT) on Wikipedia to conform with new disease definitions announced by the World Health Organization.
Currently, there is not a stand-alone TGCT page. It instead redirects to the giant-cell tumor of the tendon sheath (GCT-TS) page, which does not include TGCT terminology. This would suggest TGCT is solely a synonym for GCT-TS, which is incorrect. According to literature, TGCT is also closely related (and some say interchangeable) with pigmented villonodular synovitis (PVNS).
We’ve listed a several sources (and related quotes) below for reference with the discussion. As seen within these quotes, the term “tenosynovial giant cell tumor” or “TGCT” is used by leading health organizations and in connection with mentions of both pigmented villonodular synovitis (PVNS) and giant-cell tumor of the tendon sheath (GCT-TS):
Though I understand that PVNS and GCT-TS are not synonyms, (and thus may not be candidates for a direct merge together), the two conditions are closely connected to TGCT. Because the term “tenosynovial giant cell tumor” or “TGCT” is used by medical professionals and patients, we believe it’s important the condition be accurately defined on Wikipedia. By initiating this discussion, our hope is to gain consensus among the community for how to go about doing so.
Thank you for your consideration. Jon Gray ( talk) 01:25, 12 April 2019 (UTC)
References
{{
cite journal}}
: Cite journal requires |journal=
(
help)
{{
cite journal}}
: Cite journal requires |journal=
(
help); Explicit use of et al. in: |author=
(
help)
Have I understood this correctly that TGCT is a group of cancers primarily consisting of PVNS and GCT-TS. Both GCT-TS and PVNS are most commonly referred to as TGCT in patient–doctor conversations and you believe that for these reasons both PVNS and GCT-TS should be discussed on the same page, namely TGCT. If that is the case I would support this proposal trusting your judgement that this would be better for patients looking to read more about TGCT. It seems like proposed mergers sadly are quite little discussion so I would suggest that if you don't want to perform the merge due to not enough discussion after one week I would suggest moving the discussion to the much more active requested moves. (Merger proposal would be more suitable though if it was more active.) Trialpears ( talk) 13:01, 18 April 2019 (UTC)
Hi all, posting here on behalf of Daiichi Sankyo, which is a client of my employer, Porter Novelli.
Previously, there has been some initial discussion about merging Pigmented villonodular synovitis (PVNS) and Giant-cell tumor of the tendon sheath (GCT-TS) into the same article. This is because the medical consensus is that PVNS and GCT-TS are variations of the same condition: Tenosynovial giant cell tumor (TGCT). I would now like to propose that both of these articles be merged into a new tenosynovial giant cell tumor article, which I have drafted here. This new article draft includes content from both the PVNS and GCT-TS articles (specific diffs are linked on the draft’s talk page), as well as additional research, including context on the relationship between PVNS and GCT-TS (also called localized TGCT and diffuse TGCT, respectively) and the ways in which they differ. I’ve done my best to align the draft with WP:MOSMED and provide rigorous, high-quality medical sources throughout.
@ Klbrain, Trialpears, Spintendo, and Rod57: Pinging you since you've been involved in these discussions before.
Due to my conflict of interest, I will not be editing any mainspace articles related to these topics directly. I appreciate any help or feedback regarding this article merge. Thank you! Mary Gaulke ( talk) 20:18, 16 July 2020 (UTC)
This redirect does not require a rating on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||
|
The contents of the Pigmented villonodular synovitis page were merged into Tenosynovial giant cell tumor on 6 August 2020 and it now redirects there. For the contribution history and old versions of the merged article please see its history. |
The
Wikimedia Foundation's
Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see
WP:PAID. For advice about reviewing paid contributions, see
WP:COIRESPONSE.
|
You should certainly add the article. You may want to categorize it with other joint conditions. - Cyborg Ninja 10:18, 27 July 2007 (UTC)
Worst case is not joint replacement. It is amputation. I know that first hand. PVNS survivor. — Preceding unsigned comment added by 2602:301:77E2:C6F0:E950:8ECA:A225:914C ( talk) 03:40, 2 May 2017 (UTC)
This edit request by an editor with a conflict of interest has now been answered. |
NOTE: I am proposing this edit for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.
I am submitting this edit request to bring your attention to the fact that the World Health Organization reclassified pigmented villonodular synovitis (PVNS) and giant-cell tumor of the tendon sheath (GCT-TS) to “tenosynovial giant cell tumor” or “TGCT” in 2013 in its 4th edition of WHO Classification of Tumours of Soft Tissue and Bone [1] (paid subscription required) to encompass a family of lesions in the soft tissue surrounding large & small joints, which all share a common pathogenesis.
As you know, this is a rare disease with very limited online resources, and the scientific and medical community are continually learning more about the condition. There are several resources containing information about TGCT, and a few are provided below, which should not be considered all-inclusive. Publications about TGCT have been posted by:
We gather it is your objective to ensure the community has as much accurate and up-to-date information possible. Toward that end, we’re requesting that the existing PVNS page be updated to include “TGCT” as an overarching name for the condition as adopted by the World Health Organization and the National Organization for Rare Disorders.
Thank you for your consideration. Jon Gray ( talk) 22:55, 31 October 2018 (UTC)
References
Tenosynovial giant cell tumor (TGCT), previously pigmented villonodular synovitis (PVNS), is a rare, proliferative neoplasm affecting the synovial lining of joints, bursae, and tendons sheaths.
{{
cite journal}}
: Cite journal requires |journal=
(
help)CS1 maint: multiple names: authors list (
link)
{{
cite journal}}
: Cite journal requires |journal=
(
help)CS1 maint: multiple names: authors list (
link)
{{
cite web}}
: Missing or empty |title=
(
help)
{{
cite web}}
: Missing or empty |title=
(
help)
{{
cite web}}
: Missing or empty |title=
(
help)
{{
requested move}}
specifically as a controversial move request process requiring discussion amongst the wider community. More information may be found at
requested moves.If choice number two above is your intention, kindly change the {{
request edit}}
template's answer parameter to read from |ans=yes
to |ans=no
Regards,
Spintendo
07:53, 1 November 2018 (UTC)
This edit request by an editor with a conflict of interest was declined. Per MOS:LEADLINK. |
NOTE: I am proposing this edit for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.
@ Spintendo: As a follow up to your request for clarification, our request is submitted with the intention of adding a passage to the existing first sentence of this page which introduces diffuse-type tenosynovial giant cell tumor as an alternate name for PVNS. Requested verbatim addition (bolded) and sourcing follow:
Thank you for your consideration. Jon Gray ( talk) 16:05, 6 December 2018 (UTC)
References
Tenosynovial giant cell tumour, diffuse type; Synonyms: Diffuse-type giant cell tumour; pigmented villonodular synovitis; pigmented villonodular, tenosynovitis
Regards, Spintendo 02:05, 7 December 2018 (UTC)
References
NOTE: I am seeking clarification for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.
@ Spintendo: Thanks for your response. To clarify, are you/the guideline suggesting that introducing the alternate term for the condition may be better suited later in the article? If so, we're happy to submit an alternate recommendation for the edit to abide by that guideline. Please let me know your thoughts. Jon Gray ( talk) 22:18, 7 December 2018 (UTC)
This edit request by an editor with a conflict of interest has now been answered. |
NOTE: I am re-flagging the previous request for additional clarification for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.
Following up on the previous communication, I am re-flagging our request for additional clarification (submitted 12/7/2018) to the declined edit request in the hopes that @ Spintendo: or another COI editor can provide clarity on whether or not introducing the alternate term for the condition may be better suited later in the article (perhaps the Classification section) as to not violate MOS:LEADLINK. If so, I can submit a revised edit request with verbatim language and sourcing for consideration.
Thank you. Jon Gray ( talk) 00:04, 11 January 2019 (UTC)
References
Notes
Pinging @ Rod57: for their input on this, as they are the editor who created the redirect for TGCT that the COI editor is attempting to place in this article. Are you able to confirm that these conditions, TGCT and PVS, are the same? Please advise if possible, thanks! Spintendo 00:53, 11 January 2019 (UTC)
NOTE: I am proposing this edit for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.
Thank you both for your responses!
@ Spintendo:, as @ Rod57: mentioned, I included references from third-parties ( World Health Organization and National Institutes of Health [1]; [2] to validate the claim that tenosynovial giant cell tumor (TGCT) was introduced as an alternate name for PVNS. Both were referenced in the original request (dated 10/31/18, which required follow-up clarification/verbatim recommendations from me) and the WHO reference was included as the primary reference in our follow up request (dated 12/6/18). (The cross-linked Wiki page was not intended to serve as a source to add the alternate title for the condition to the article itself, but was related to the secondary request for page cross-linking. Apologies for any confusion on that.)
However, I would like to re-submit our request to include TGCT as an alternate name for PVNS in the article. Please see below for an updated edit request, which hopefully will avoid any issues with MOS:LEADLINK. The source for this requested addition is the aforementioned World Health Organization reference which identifies tenosynovial giant cell tumor (diffuse type) as a synonym for PVNS (see quote in reference code below confirming the conditions as synonyms).
Classification
Our request is submitted with the intention of adding a sentence to the end of the “Classification” section to introduce diffuse-type tenosynovial giant cell tumor (TGCT) as an alternate name for PVNS. The requested verbatim addition and sourcing (from World Health Organization, which validates the synonyms – see quote in reference) follow:
Thanks again for your time and consideration. Jon Gray ( talk) 23:19, 28 January 2019 (UTC)
References
Tenosynovial giant cell tumor (TGCT), previously pigmented villonodular synovitis (PVNS), is a rare, proliferative neoplasm affecting the synovial lining of joints, bursae, and tendons sheaths.
{{
cite journal}}
: Cite journal requires |journal=
(
help)CS1 maint: multiple names: authors list (
link)
{{
cite journal}}
: Cite journal requires |journal=
(
help)CS1 maint: multiple names: authors list (
link)
Tenosynovial giant cell tumour, diffuse type; Synonyms: Diffuse-type giant cell tumour; pigmented villonodular synovitis; pigmented villonodular, tenosynovitis
Please move to WP:MERGEREQ
Please feel free to contact
Wikipedia:WikiProject Merge if you require additional assistance with your request.
Regards,
Spintendo
00:45, 29 January 2019 (UTC)
Notes
NOTE: I am proposing this discussion for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.
At the recommendation of a conflict of interest editor who I’d previously contacted about adding Tenosynovial giant cell tumor (TGCT) as a synonym for diffuse-type pigmented villonodular synovitis (PVNS), I am opening this merger discussion to ask the community for guidance on how to go about updating the language describing tenosynovial giant cell tumor (TGCT) on Wikipedia to conform with new disease definitions announced by the World Health Organization.
Currently, there is not a stand-alone TGCT page. It instead redirects to the giant-cell tumor of the tendon sheath (GCT-TS) page, which does not include TGCT terminology. This would suggest TGCT is solely a synonym for GCT-TS, which is incorrect. According to literature, TGCT is also closely related (and some say interchangeable) with pigmented villonodular synovitis (PVNS).
We’ve listed a several sources (and related quotes) below for reference with the discussion. As seen within these quotes, the term “tenosynovial giant cell tumor” or “TGCT” is used by leading health organizations and in connection with mentions of both pigmented villonodular synovitis (PVNS) and giant-cell tumor of the tendon sheath (GCT-TS):
Though I understand that PVNS and GCT-TS are not synonyms, (and thus may not be candidates for a direct merge together), the two conditions are closely connected to TGCT. Because the term “tenosynovial giant cell tumor” or “TGCT” is used by medical professionals and patients, we believe it’s important the condition be accurately defined on Wikipedia. By initiating this discussion, our hope is to gain consensus among the community for how to go about doing so.
Thank you for your consideration. Jon Gray ( talk) 01:25, 12 April 2019 (UTC)
References
{{
cite journal}}
: Cite journal requires |journal=
(
help)
{{
cite journal}}
: Cite journal requires |journal=
(
help); Explicit use of et al. in: |author=
(
help)
Have I understood this correctly that TGCT is a group of cancers primarily consisting of PVNS and GCT-TS. Both GCT-TS and PVNS are most commonly referred to as TGCT in patient–doctor conversations and you believe that for these reasons both PVNS and GCT-TS should be discussed on the same page, namely TGCT. If that is the case I would support this proposal trusting your judgement that this would be better for patients looking to read more about TGCT. It seems like proposed mergers sadly are quite little discussion so I would suggest that if you don't want to perform the merge due to not enough discussion after one week I would suggest moving the discussion to the much more active requested moves. (Merger proposal would be more suitable though if it was more active.) Trialpears ( talk) 13:01, 18 April 2019 (UTC)
Hi all, posting here on behalf of Daiichi Sankyo, which is a client of my employer, Porter Novelli.
Previously, there has been some initial discussion about merging Pigmented villonodular synovitis (PVNS) and Giant-cell tumor of the tendon sheath (GCT-TS) into the same article. This is because the medical consensus is that PVNS and GCT-TS are variations of the same condition: Tenosynovial giant cell tumor (TGCT). I would now like to propose that both of these articles be merged into a new tenosynovial giant cell tumor article, which I have drafted here. This new article draft includes content from both the PVNS and GCT-TS articles (specific diffs are linked on the draft’s talk page), as well as additional research, including context on the relationship between PVNS and GCT-TS (also called localized TGCT and diffuse TGCT, respectively) and the ways in which they differ. I’ve done my best to align the draft with WP:MOSMED and provide rigorous, high-quality medical sources throughout.
@ Klbrain, Trialpears, Spintendo, and Rod57: Pinging you since you've been involved in these discussions before.
Due to my conflict of interest, I will not be editing any mainspace articles related to these topics directly. I appreciate any help or feedback regarding this article merge. Thank you! Mary Gaulke ( talk) 20:18, 16 July 2020 (UTC)